Companies
Codexis
machine-learning plus bioinformatics plus automated lab compress design-build-test to about one week, trained on 20+ years of experimental data.
- Country
- United States
- Ticker
- CDXS
ISO 9001
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| crop-biotech | ✓ | ✓ | — | ✓ |
| enzymes-biocatalysis | ✓ | ✓ | ✓ | ✓ |
| specialty-fine-chem | ✓ | ✓ | — | ✓ |
| therapeutics-platforms | ✓ | ✓ | — | ✓ |
Regulatorsepafdaemanmpareachmoa-chinaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | In July 2026, Codexis raised approximately $25 million in net proceeds through equity financing. (2026-06-30) | ir.codexis.com · fool.com |
| Capacity | Targeting 0.5 kilogram scale for siRNA production in the ECO Innovation Lab by the end of 2026; future GMP facility aims for larger scale. (2026-08-18) | fool.com |
| Certification | ISO 9001 certified for its in-house manufacturing suite. (2026-03-11) | ir.codexis.com |
| Regulatory approval | Currently engaged with FDA's Emerging Technologies team regarding the ECO Synthesis platform; no product-specific commercial approvals cited. (2026-08-31) | fool.com · sec.gov |
| Production site | Redwood City, California (headquarters/in-house manufacturing/ECO Innovation Lab); Hayward, California (future GMP manufacturing facility under construction). CMO facilities in Austria, Italy, and the UK. (2026-03-11) | ir.codexis.com · codexis.com |
| Headcount | 146 full-time and part-time employees. (2025-12-31) | ir.codexis.com |
| Revenue | $70.4 million for fiscal year 2025. (2025-12-31) | ir.codexis.com |
Independent sources: fool.com · sec.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biocatalysis in petrochemistry | enzymes-biocatalysis | Low | → |
| Biosynthetic specialty & fine chemicals (precision fermentation, biocatalysis, biorefinery) | specialty-fine-chem | Medium | → |
| Chemoenzymatic API synthesis (biocatalytic small-molecule manufacturing) | therapeutics-platforms | Low | → |
| Enzymatic polymer synthesis in vitro | enzymes-biocatalysis | Medium | → |
| Strain engineering (synbio CRO) | crop-biotech | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.